Growth Metrics

Eli Lilly (LLY) Treasury Shares (2016 - 2026)

Eli Lilly filings provide 18 years of Treasury Shares readings, the most recent being $3.0 billion for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 5986.87% to $3.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.0 billion, a 5986.87% increase, with the full-year FY2025 number at $3.0 billion, changed 0.0% from a year prior.
  • Treasury Shares hit $50.0 million in Q4 2025 for Eli Lilly, up from $3.3 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $50.0 million in Q4 2024 to a low of -$2.5 million in Q3 2021.
  • Median Treasury Shares over the past 5 years was $450000.0 (2022), compared with a mean of $6.0 million.
  • Biggest five-year swings in Treasury Shares: plummeted 98.91% in 2024 and later surged 9114.68% in 2025.
  • Eli Lilly's Treasury Shares stood at $3.0 billion in 2022, then tumbled by 98.53% to $44.2 million in 2023, then soared by 6716.74% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025, then changed by 0.0% to $3.0 billion in 2026.
  • The last three reported values for Treasury Shares were $3.0 billion (Q1 2026), $3.0 billion (Q4 2025), and $3.0 billion (Q3 2025) per Business Quant data.